Ambien vs. Quviviq

See how Ambien and Quviviq compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Ambien is a GABA-A sedative approved only for trouble falling asleep, while Quviviq is a dual orexin blocker approved for falling asleep, staying asleep, or both.

  • Ambien is available as a low-cost generic, while Quviviq has no generic and costs substantially more per month.

  • Both are Schedule IV controlled substances with warnings for complex sleep behaviors like sleepwalking or sleep-driving.

Ambien vs. Quviviq Drug Summary

Ambien

Ambien (zolpidem) is a non-benzodiazepine sedative-hypnotic that works on GABA-A receptors in the brain. It's FDA-approved for short-term treatment of insomnia in people who have trouble falling asleep. It comes as an immediate-release tablet taken once nightly on an empty stomach.

Quviviq

Quviviq (daridorexant) is a dual orexin receptor antagonist that blocks the brain's wake-promoting orexin signals rather than boosting GABA. It's FDA-approved for insomnia in adults who have trouble falling asleep, staying asleep, or both. It's taken as an oral tablet once nightly.

Ambien vs. Quviviq Side Effects

Ambien

Most common
dizziness (up to 23.5%)
headache (up to 19%)
somnolence (up to 15%)
nausea (up to 10%)

Quviviq

Most common
dizziness (up to 5%)
headache (up to 6.5%)
somnolence (up to 7%)
nausea (up to 5%)

Ambien vs. Quviviq Dosage

Ambien

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once nightly At the start
Maximum dose 10 mg once nightly If needed
Dose changes 1 increase As tolerated

Quviviq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg once nightly At the start
Maximum dose 50 mg once nightly If needed
Dose changes 1 increase As tolerated

Ambien vs. Quviviq Indications

Ambien

Ambien is approved only for short-term insomnia treatment, specifically to help people fall asleep faster. It is not approved for insomnia where the main issue is staying asleep, and it isn't meant for long-term nightly use.

  • Helps you fall asleep faster

  • Approved for short-term use only

  • Not approved for children

  • Available as a low-cost generic

Quviviq

Quviviq is approved for adults with insomnia involving trouble falling asleep, staying asleep, or both. Unlike Ambien, its labeling addresses sleep maintenance as well as sleep onset, and it isn't restricted to short-term use.

  • Helps with falling and staying asleep

  • No short-term use restriction in labeling

  • Not approved for narcolepsy

  • Approved for adults only

Ambien vs. Quviviq Pros and Cons

Ambien

Ambien has decades of real-world use and is available as an inexpensive generic, but it only targets sleep onset, not staying asleep. It carries a higher labeled rate of dizziness and next-day drowsiness than Quviviq.

Pros

  • Inexpensive generic, roughly $15 to $90 a month

  • Fast onset when taken on an empty stomach

  • Decades of real-world clinical use

  • Dosing tailored by sex (5 mg or 10 mg)

Cons

  • Higher labeled rates of dizziness and drowsiness

  • Not approved for staying asleep

  • Prominent complex sleep behavior warnings

  • Not approved for long-term nightly use

Quviviq

Quviviq covers both falling asleep and staying asleep, with lower labeled rates of dizziness and morning grogginess than Ambien. It's newer to market and, without a generic, costs far more out of pocket each month.

Pros

  • Approved for both falling and staying asleep

  • Lower labeled rates of dizziness and drowsiness

  • No withdrawal symptoms seen in clinical trials

  • Newer mechanism that blocks orexin, not GABA

Cons

  • No generic; roughly $520 to $685 a month

  • Contraindicated in narcolepsy

  • Less long-term real-world data than Ambien

  • Dose reduction needed with liver impairment

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.